Company Number: 14123504

Analysis Date: 2025-07-29 15:15 UTC

Financial Health Assessment for PXEL LTD

---

1. Financial Health Score: D

Explanation:
PXEL LTD's latest financial statements reveal significant signs of financial distress. The company has moved from a modestly positive net asset position of £1,000 in the previous year to a negative net asset position of £6,920 in 2024. This indicates the company’s liabilities now exceed its assets, akin to a patient whose vital signs (financial metrics) have deteriorated from stable to critical. As a micro-entity in its infancy, this financial imbalance signals a need for urgent attention to avoid further decline.

---

2. Key Vital Signs (Financial Metrics)

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	484	1,000	Shrinking cash/receivables; reduced liquidity
Current Liabilities	7,404	(unknown)	Sharp increase in short-term debts; cash crunch
Net Current Assets (Working Capital)	-6,920	1,000	Shift from positive to heavily negative; poor short-term financial health
Net Assets (Shareholders’ Funds)	-6,920	1,000	Negative equity indicates liabilities exceed assets; potential solvency concerns

Interpretation:

• Healthy cash flow is like a strong heartbeat sustaining company operations. Here, the significant negative working capital suggests PXEL LTD is experiencing cash flow difficulties, akin to symptoms of distress.
• The deterioration from positive net assets to negative signals the company is operating with a deficit, which could limit its ability to fund growth or meet obligations.
• The increase in current liabilities without a corresponding increase in current assets suggests the company may be relying on short-term borrowing or delaying payments, a risky practice if prolonged.

---

3. Diagnosis: Financial Condition

PXEL LTD, incorporated in 2022 and operating in business and domestic software development, is showing early-stage financial distress symptoms. The rapid decline in net assets and net current assets over a single year indicates the business is burning through capital or accumulating more liabilities than assets can cover. The small scale (micro entity) and single-employee structure suggest limited operational scale, which can constrain cash inflows and resilience.

The negative net current assets are a "red flag"—akin to a patient showing signs of organ stress—indicating potential liquidity problems. Without sufficient short-term assets, PXEL LTD may struggle to pay suppliers, creditors, or meet other obligations on time.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Cash Flow Management:

   • Implement strict cash flow forecasting to anticipate shortfalls.
   • Negotiate extended payment terms with creditors to ease immediate cash pressures.
   • Accelerate collections from any debtors or clients.

2. Cost Control:

   • Review all expenses to eliminate non-essential costs and preserve cash resources.
   • Optimize operational efficiency, considering automation or outsourcing if cost-effective.

3. Capital Injection:

   • Consider an equity injection from the sole shareholder or external investors to shore up negative net assets and improve solvency.
   • Explore grants or funding options tailored for small tech companies.

4. Financial Monitoring:

   • Establish monthly financial reviews to track key indicators (working capital, cash balances).
   • Engage a financial advisor or accountant for ongoing diagnostics and tailored advice.

5. Strategic Planning:

   • Reassess business model viability and revenue generation strategies to enhance profitability.
   • Diversify client base or product offerings to reduce dependence on limited revenue streams.

---

Executive Summary

PXEL LTD is currently in a fragile financial state, marked by a significant decline in net assets and negative working capital, signaling liquidity and solvency challenges. Immediate focus on cash flow management, cost control, and possible capital injection is critical to restore financial health and ensure sustainable operations. Early intervention will improve the company's prognosis and enable it to navigate growth hurdles effectively.